1
|
Samara ET, Saltybaeva N, Sans Merce M, Gianolini S, Ith M. Systematic literature review on the benefit of patient protection shielding during medical X-ray imaging: Towards a discontinuation of the current practice. Phys Med 2022; 94:102-109. [PMID: 35030383 DOI: 10.1016/j.ejmp.2021.12.016] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/24/2021] [Revised: 12/15/2021] [Accepted: 12/28/2021] [Indexed: 11/25/2022] Open
Abstract
PURPOSE Patient shielding during medical X-ray imaging has been increasingly criticized in the last years due to growing evidence that it often provides minimal benefit and may even compromise image quality. In Europe, and as also shown in a short assessment in Switzerland, the use of patient shielding is inhomogeneous. The aim of this study was to systematically review recent literature in order to assess benefits and appraise disadvantages related to the routine use of patient shielding. METHODS To evaluate benefits and disadvantages related to the application of patient shielding in radiological procedures, a systematic literature review was performed for CT, radiography, mammography and fluoroscopy-guided medical X-ray imaging. In addition, reports from medical physics societies and authorities of different countries were considered in the evaluation. RESULTS The literature review revealed 479 papers and reports on the topic, from which 87 qualified for closer analysis. The review considered in- and out-of-plane patient shielding as well as shielding for pregnant and pediatric patients. Dose savings and other dose and non-dose related effects of patient shielding were considered in the evaluation. CONCLUSIONS Although patient shielding has been used in radiological practice for many years, its use is no longer undisputed. The evaluation of the systematic literature review of recent studies and reports shows that dose savings are rather minimal while significant dose- and non-dose-related detrimental effects are present. Consequently, the routine usage of patient protection shielding in medical X-ray imaging can be safely discontinued for all modalities and patient groups.
Collapse
Affiliation(s)
- Eleni Theano Samara
- Radiation Protection Unit, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
| | - Natalia Saltybaeva
- Radiation Protection Unit, University Hospital Zurich, University of Zurich, Zurich, Switzerland
| | - Marta Sans Merce
- Department of Radiology and Medical Informatics, University of Geneva, Geneva, Switzerland
| | | | - Michael Ith
- Department of Diagnostic, Interventional and Pediatric Radiology (DIPR), Inselspital, Bern University Hospital, University of Bern, Switzerland
| |
Collapse
|
2
|
Verhaegen F, Dubois L, Gianolini S, Hill MA, Karger CP, Lauber K, Prise KM, Sarrut D, Thorwarth D, Vanhove C, Vojnovic B, Weersink R, Wilkens JJ, Georg D. ESTRO ACROP: Technology for precision small animal radiotherapy research: Optimal use and challenges. Radiother Oncol 2018; 126:471-478. [PMID: 29269093 DOI: 10.1016/j.radonc.2017.11.016] [Citation(s) in RCA: 73] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2017] [Accepted: 11/21/2017] [Indexed: 11/30/2022]
Abstract
Many radiotherapy research centers have recently installed novel research platforms enabling the investigation of the radiation response of tumors and normal tissues in small animal models, possibly in combination with other treatment modalities. Many more research institutes are expected to follow in the coming years. These novel platforms are capable of mimicking human radiotherapy more closely than older technology. To facilitate the optimal use of these novel integrated precision irradiators and various small animal imaging devices, and to maximize the impact of the associated research, the ESTRO committee on coordinating guidelines ACROP (Advisory Committee in Radiation Oncology Practice) has commissioned a report to review the state of the art of the technology used in this new field of research, and to issue recommendations. This report discusses the combination of precision irradiation systems, small animal imaging (CT, MRI, PET, SPECT, bioluminescence) systems, image registration, treatment planning, and data processing. It also provides guidelines for reporting on studies.
Collapse
Affiliation(s)
- Frank Verhaegen
- Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands
| | - Ludwig Dubois
- Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands
| | | | - Mark A Hill
- CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Gray Laboratories, UK
| | - Christian P Karger
- Department of Medical Physics in Radiation Oncology, German Cancer Research Center, Heidelberg, Germany; National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany
| | - Kirsten Lauber
- Department of Radiation Oncology, University Hospital, Ludwig-Maximilians-University of Munich, Germany
| | - Kevin M Prise
- Centre for Cancer Research & Cell Biology, Queen's University Belfast, UK
| | - David Sarrut
- Université de Lyon, CREATIS, CNRS UMR5220, Inserm U1044, INSA-Lyon, Université Lyon 1, Centre Léon Bérard, France
| | - Daniela Thorwarth
- Section for Biomedical Physics, Department of Radiation Oncology, University Hospital Tübingen, Germany
| | - Christian Vanhove
- Institute Biomedical Technology (IBiTech), Medical Imaging and Signal Processing (MEDISIP), Ghent University, Belgium
| | - Boris Vojnovic
- CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Gray Laboratories, UK
| | - Robert Weersink
- Department of Radiation Oncology, University of Toronto, Department of Radiation Medicine, Princess Margaret Hospital, Canada
| | - Jan J Wilkens
- Department of Radiation Oncology, Technical University of Munich, Klinikum rechts der Isar, Germany
| | - Dietmar Georg
- Division of Medical Radiation Physics, Department of Radiation Oncology and Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Austria
| |
Collapse
|
3
|
Palorini F, Botti A, Carillo V, Gianolini S, Improta I, Iotti C, Rancati T, Cozzarini C, Fiorino C. Bladder dose-surface maps and urinary toxicity: Robustness with respect to motion in assessing local dose effects. Phys Med 2016; 32:506-11. [PMID: 27053449 DOI: 10.1016/j.ejmp.2016.03.006] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/04/2015] [Revised: 02/29/2016] [Accepted: 03/03/2016] [Indexed: 11/28/2022] Open
Abstract
The purpose of this study was to quantify the impact of inter-fraction modifications of bladder during RT of prostate cancer on bladder dose surface maps (DSM). Eighteen patients treated with daily image-guided Tomotherapy and moderate hypofractionation (70-72.8Gy at 2.5-2.6Gy/fr in 28 fractions and full bladder) were considered. Bladder contours were delineated on co-registered daily Megavoltage CT (MVCT) by a single observer and copied on the planning CT to generate dose-volume/surface histograms (DVH/DSH) and bladder DSMs. Discrepancies between planned and daily absorbed doses were analyzed through the average of individual systematic errors, the population systematic errors and the population random errors for the DVH/DSHs and DSMs. In total, 477 DVH/DSH and 472 DSM were available. DSH and DVH showed small population systematic errors of absolute surfaces (<3.4cm(2)) and volumes (<8.4cm(3)) at the highest doses. The dose to the posterior bladder base assessed on DSMs showed a mean systematic error below 1Gy, with population systematic and random errors within 4 and 3Gy, respectively. The region surrounding this area shows higher mean systematic errors (1-3Gy), population systematic (8-11Gy) and random (5-7Gy) errors. In conclusion, DVH/DSH and DSMs are quite stable with respect to inter-fraction variations in the high-dose region, within about 2cm from bladder base. Larger systematic variations occur in the anterior portion and cranially 2.5-3.5cm from the base. Results suggest that dose predictors related to the high dose area (including the trigone dose) are likely to be sufficiently reliable with respect to the expected variations due to variable bladder filling.
Collapse
Affiliation(s)
- F Palorini
- Medical Physics, San Raffaele Scientific Institute IRCCS, Milan, Italy.
| | - A Botti
- Medical Physics, Arcispedale S. M. Nuova, Reggio Emilia, Italy
| | - V Carillo
- Medical Physics, San Raffaele Scientific Institute IRCCS, Milan, Italy
| | - S Gianolini
- Medical Software Solutions GmbH, Hagendorn, Switzerland
| | - I Improta
- Medical Physics, San Raffaele Scientific Institute IRCCS, Milan, Italy
| | - C Iotti
- Radiotherapy, Arcispedale S. M. Nuova, Reggio Emilia, Italy
| | - T Rancati
- Prostate Cancer Program, Istituto Nazionale dei Tumori IRCCS, Milan, Italy
| | - C Cozzarini
- Radiotherapy, San Raffaele Scientific Institute, Milan, Italy
| | - C Fiorino
- Medical Physics, San Raffaele Scientific Institute IRCCS, Milan, Italy
| |
Collapse
|
4
|
Pellanda AF, Urso P, Gianolini S, De Bari B, Ballerini G, Negretti L, Vite C, Corradini N. EP-1296: A correlation between PTV dosimetric criteria and pathological responsein rectal cancer patients. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32546-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
5
|
Palorini F, Cozzarini C, Gianolini S, Rancati T, Carillo V, Botti A, Iotti C, Valdagni R, Fiorino C. Bladder Dose-Surface Maps show Evidence of Spatial Effects for the Risk of Acute Urinary Toxicity after Moderate Hypofractionated Radiation for Prostate Cancer. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.165] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
6
|
Botti A, Carillo V, Cagni E, Cozzarini C, Gianolini S, Mezzenga E, Muraglia A, Iori M, Valdagni R, Fiorino C. EP-1254: Analysis of inter-fraction bladder motion during prostate treatments by daily MVCT Tomotherapy imaging. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33560-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
7
|
Carillo V, Cozzarini C, Chietera A, Perna L, Gianolini S, Maggio A, Botti A, Rancati T, Valdagni R, Fiorino C. Correlation between surrogates of bladder dosimetry and dose-volume histograms of the bladder wall defined on MRI in prostate cancer radiotherapy. Radiother Oncol 2012. [PMID: 23182056 DOI: 10.1016/j.radonc.2012.10.001] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The correlation between bladder dose-wall-histogram (DWH) and dose-volume-histogram (DVH), dose-surface-histogram (DSH), and DVH-5/10 was investigated in a group of 28 patients; bladder walls were drawn on T2-MRI. DVH showed the poorest correlation with DWH; DSH or DVH-5/10 should be preferred in planning; absolute DVH may be used for radical patients, although less robust.
Collapse
|
8
|
Carillo V, Cozzarini C, Perna L, Calandra M, Gianolini S, Rancati T, Spinelli AE, Vavassori V, Villa S, Valdagni R, Fiorino C. Contouring Variability of the Penile Bulb on CT Images: Quantitative Assessment Using a Generalized Concordance Index. Int J Radiat Oncol Biol Phys 2012; 84:841-6. [DOI: 10.1016/j.ijrobp.2011.12.057] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2011] [Revised: 12/14/2011] [Accepted: 12/18/2011] [Indexed: 11/25/2022]
|
9
|
La Macchia M, Fellin F, Amichetti M, Cianchetti M, Gianolini S, Paola V, Lomax AJ, Widesott L. Systematic evaluation of three different commercial software solutions for automatic segmentation for adaptive therapy in head-and-neck, prostate and pleural cancer. Radiat Oncol 2012; 7:160. [PMID: 22989046 PMCID: PMC3493511 DOI: 10.1186/1748-717x-7-160] [Citation(s) in RCA: 116] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2012] [Accepted: 09/05/2012] [Indexed: 12/11/2022] Open
Abstract
Purpose To validate, in the context of adaptive radiotherapy, three commercial software solutions for atlas-based segmentation. Methods and materials Fifteen patients, five for each group, with cancer of the Head&Neck, pleura, and prostate were enrolled in the study. In addition to the treatment planning CT (pCT) images, one replanning CT (rCT) image set was acquired for each patient during the RT course. Three experienced physicians outlined on the pCT and rCT all the volumes of interest (VOIs). We used three software solutions (VelocityAI 2.6.2 (V), MIM 5.1.1 (M) by MIMVista and ABAS 2.0 (A) by CMS-Elekta) to generate the automatic contouring on the repeated CT. All the VOIs obtained with automatic contouring (AC) were successively corrected manually. We recorded the time needed for: 1) ex novo ROIs definition on rCT; 2) generation of AC by the three software solutions; 3) manual correction of AC. To compare the quality of the volumes obtained automatically by the software and manually corrected with those drawn from scratch on rCT, we used the following indexes: overlap coefficient (DICE), sensitivity, inclusiveness index, difference in volume, and displacement differences on three axes (x, y, z) from the isocenter. Results The time saved by the three software solutions for all the sites, compared to the manual contouring from scratch, is statistically significant and similar for all the three software solutions. The time saved for each site are as follows: about an hour for Head&Neck, about 40 minutes for prostate, and about 20 minutes for mesothelioma. The best DICE similarity coefficient index was obtained with the manual correction for: A (contours for prostate), A and M (contours for H&N), and M (contours for mesothelioma). Conclusions From a clinical point of view, the automated contouring workflow was shown to be significantly shorter than the manual contouring process, even though manual correction of the VOIs is always needed.
Collapse
Affiliation(s)
- Mariangela La Macchia
- Agenzia Provinciale per la Protonterapia, Via F.lli Perini, 181, 38122, Trento, Italy
| | | | | | | | | | | | | | | |
Collapse
|
10
|
Perna L, Cozzarini C, Carillo V, Spinelli A, Gianolini S, Rancati T, Vavassori V, Villa S, Valdagni R, Fiorino C. EP-1441 VARIABILITY IN PENILE BULB CONTOURING: QUANTITATIVE ASSESSMENT BY USING THE GENERALIZED DICE CONCORDANCE INDEX. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71774-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
11
|
Carillo V, Cozzarini C, Perna L, Chietera A, Bianconi C, Brenna S, Gianolini S, Rancati T, Valdagni R, Fiorino C. PD-0397 CORRELATION BETWEEN SURROGATES OF BLADDER DOSIMETRY AND DVH OF THE BLADDER WALL DEFINED ON MRI IMAGING. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)70736-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
12
|
Maggiulli E, Fiorino C, Passoni P, Broggi S, Gianolini S, Salvetti C, Slim N, Di Muzio NG, Calandrino R. Characterisation of rectal motion during neo-adjuvant radiochemotherapy for rectal cancer with image-guided tomotherapy: implications for adaptive dose escalation strategies. Acta Oncol 2012; 51:318-24. [PMID: 22497434 DOI: 10.3109/0284186x.2012.666358] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
BACKGROUND Interest in boosting the dose to the tumour during neo-adjuvant radiochemotherapy for rectal cancer is ever increasing, especially within the frame of adaptive radiotherapy. Rectal motion remains a potentially important obstacle to the full exploitation of this approach and needs to be carefully investigated. MATERIAL AND METHODS The main purposes of this work were to: a) quantify rectal motion on all fractions of a treatment course; and b) assess margins for adaptive boosting in the second part of the treatment in order to benefit of tumour reduction during treatment. Ten consecutive patients treated with image-guided tomotherapy (41.4 Gy, 18 fractions) were selected. The cranial half of the rectum (subject to motion) was contoured by a single observer on daily MVCTs. The variations of rectal volume and of the envelope of rectum positions were investigated (169 MVCTs). The impact of applying different margins to the rectum in including all its possible positions was also investigated when considering the planning kVCT, the first fraction MVCT, the half-treatment MVCT or the median rectal contours of the whole or second half of treatment as reference volumes. RESULTS Rectal volume reduced during treatment in all patients, with a significant time-trend in 6/10 patients. The median values of the envelope volumes were 129 cm(3) and 87 cm(3) in the first and second half of the treatment, respectively. On average, 95% of the rectal envelope was included by an isotropic expansion of 12 mm and 5 mm of the median contours when considering the whole or the second half of the treatment, respectively. CONCLUSION A significant reduction of rectal volume was found in the second part of the treatment where rectal mobility was limited. As a consequence, relatively small margins may be used around the residual tumour volume when adaptive boost is delivered in the second half of the treatment.
Collapse
|
13
|
Lei M, Rickard D, Crawshaw J, Clark C, Adams E, Gianolini S, Jordan T, Whitaker S, Nisbet A, Urbano TG. 1162 poster FDG-PET GUIDED DOSE-PAINTING IN OROPHARYNGEAL SCC: WHAT IS THE EFFECT OF SEGMENTATION TECHNIQUE ON ESTIMATED TCP? Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)71284-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
14
|
Gulliford SL, Foo K, Morgan RC, Aird EG, Bidmead AM, Critchley H, Evans PM, Gianolini S, Mayles WP, Moore AR, Sánchez-Nieto B, Partridge M, Sydes MR, Webb S, Dearnaley DP. Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397. Int J Radiat Oncol Biol Phys 2010; 76:747-54. [PMID: 19540054 DOI: 10.1016/j.ijrobp.2009.02.025] [Citation(s) in RCA: 106] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2008] [Revised: 02/11/2009] [Accepted: 02/11/2009] [Indexed: 11/24/2022]
Abstract
PURPOSE Radical radiotherapy for prostate cancer is effective but dose limited because of the proximity of normal tissues. Comprehensive dose-volume analysis of the incidence of clinically relevant late rectal toxicities could indicate how the dose to the rectum should be constrained. Previous emphasis has been on constraining the mid-to-high dose range (>/=50 Gy). Evidence is emerging that lower doses could also be important. METHODS AND MATERIALS Data from a large multicenter randomized trial were used to investigate the correlation between seven clinically relevant rectal toxicity endpoints (including patient- and clinician-reported outcomes) and an absolute 5% increase in the volume of rectum receiving the specified doses. The results were quantified using odds ratios. Rectal dose-volume constraints were applied retrospectively to investigate the association of constraints with the incidence of late rectal toxicity. RESULTS A statistically significant dose-volume response was observed for six of the seven endpoints for at least one of the dose levels tested in the range of 30-70 Gy. Statistically significant reductions in the incidence of these late rectal toxicities were observed for the group of patients whose treatment plans met specific proposed dose-volume constraints. The incidence of moderate/severe toxicity (any endpoint) decreased incrementally for patients whose treatment plans met increasing numbers of dose-volume constraints from the set of V30 CONCLUSION Considering the entire dose distribution to the rectum by applying dose-volume constraints such as those tested here in the present will reduce the incidence of late rectal toxicity.
Collapse
Affiliation(s)
- Sarah L Gulliford
- Joint Department of Physics, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, Sutton, United Kingdom
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Lechner A, Blaickner M, Gianolini S, Poljanc K, Aiginger H, Georg D. Targeted radionuclide therapy: theoretical study of the relationship between tumour control probability and tumour radius for a 32P/33P radionuclide cocktail. Phys Med Biol 2008; 53:1961-74. [PMID: 18354241 DOI: 10.1088/0031-9155/53/7/011] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
As revealed by previous theoretical studies, targeted radionuclide therapy (TRT) that relies on a single beta-emitting radioisotope is likely to be inappropriate for clinical scenarios such as disseminated malignancy. For a patient with a vast number of tumours and metastases of largely differing sizes a high level of therapeutical efficiency might be achieved only for a restricted range of tumour sizes. This is due to the limited range of beta-electrons in human tissue, essentially causing the therapeutical impact to vary tremendously with tumour size. The dependence of curability on the tumour dimension is expected to be significantly altered if a radionuclide cocktail, consisting of a long-range and a short-range beta-emitter, such as (32)P and (33)P, is involved in the treatment. In this study, a radiation transport simulation was performed, using the MCNP4c2 Monte Carlo code, in order to investigate the relationship between tumour control probability (TCP) and tumour size, associated with concurrent use of (32)P and (33)P. Two different models of intratumoural distribution of cumulated activity were taken into account. One simulated an ideal radionuclide uptake in tumour tissue and the other referred to a limited radiotracer penetration. The results were examined in comparison to tumours targeted with pure (32)P, (33)P and (131)I. For both uptake scenarios a considerable reduction of the overall variation of TCP and thus an increasing chance of achieving tumour cure was observed for tumour sizes ranging from microscopic dimensions up to macroscopic diameters, if the targeted radionuclide treatment relies on a (32)P/(33)P cocktail. It was revealed that particular attention has to be given to the ratio of the (32)P and (33)P specific cumulated activities (SCA) in the tumour, since this is a significant determinant of the resulting behaviour of tumour control probability as the tumour diameter varies. This study suggests that a 32P/33P approach is more applicable to diseases that involve a variety of tumours and metastases differing in size.
Collapse
Affiliation(s)
- A Lechner
- Medical Physics Department, Radiation Safety and Applications Seibersdorf, Austrian Research Centers GmbH-ARC, 2444 Seibersdorf, Austria
| | | | | | | | | | | |
Collapse
|
16
|
Seco J, Gianolini S, Sharp G, Wu Z, Gierga D, Buettner F, Paganetti H. TU-C-M100J-05: Image Guided 4D Monte Carlo Study of the Dosimetric Effects of Intra/inter Fraction Motion in Lung Tumors. Med Phys 2007. [DOI: 10.1118/1.2761336] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
17
|
Crescenti RA, Scheib SG, Schneider U, Gianolini S. Introducing gel dosimetry in a clinical environment: customization of polymer gel composition and magnetic resonance imaging parameters used for 3D dose verifications in radiosurgery and intensity modulated radiotherapy. Med Phys 2007; 34:1286-97. [PMID: 17500460 DOI: 10.1118/1.2712042] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
Radiation sensitive gels have been used as dosimeters for clinical dose verification of different radiation therapy modalities. However, the use of gels is not widespread, because careful techniques are required to achieve the dose precision and accuracy aimed for in clinical dose verification. Here, the introduction of gel dosimetry in a clinical environment is described, including the whole chain of customizations and preparations required to introduce magnetic resonance (MR) based gel dosimetry into clinical routine. In order to standardize gel dosimetry in dose verifications for radiosurgery and intensity modulated radiotherapy (IMRT), we focused on both the customization of the gel composition and of the MR imaging parameters to increase its precision. The relative amount of the components of the normoxic, methacrylic acid based gel (MAGIC) was changed to obtain linear and steep dose response relationships. MR imaging parameters were customized for the different dose ranges used in order to lower the relative standard deviation of the measured transversal relaxation rate (R2). An optimization parameter was introduced to quantify the change in the relative standard deviation of R2 (sigma(R2,rel)) taking the increase in MR time into account. A 9% methacrylic acid gel customized for radiosurgery was found to give a linear dose response up to 40 Gy with a slope of 0.94 Gy(-1) s(-1), while a 6% methacrylic acid gel customized for IMRT had a linear range up to 3 Gy with a slope of 1.86 Gy(-1) s(-1). With the help of an introduced optimization parameter, the mean sigma(R2,rel) was improved by 13% for high doses and by 55% for low doses, without increasing MR time to unacceptable values. A mean dose resolution of less than 0.13 Gy has been achieved with the gel and imaging parameters customized for IMRT and a dose resolution from 0.97 Gy (at 5 Gy) to 2.15 Gy (at 40 Gy) for the radiosurgery dose range. The comparisons of calculated and measured relative 3D dose distributions performed for radiosurgery and IMRT showed an acceptable overall correlation. The gamma criterion for the radiosurgery verification with a voxel size of 1.5 x 1.5 x 1.5 mm3 was passed by 96.8% of the voxels (1.5 mm distance, 8% in dose). For the IMRT verification using a voxel size of 1.25 x 1.25 x 5 mm3 the gamma criterion was passed by 50.3% of the voxels (3 mm distance, 3% dose uncertainty). Using dedicated data analysis and visualization software, MR based normoxic gel dosimetry was found to be a valuable tool for clinically based dose verification, provided that customized gel compositions and MR imaging parameters are used. While high dose precision was achieved, further work is required to achieve clinically acceptable dose accuracy.
Collapse
Affiliation(s)
- Remo A Crescenti
- Department of Information Technology and Electrical Engineering, ETH, Zürich, Switzerland.
| | | | | | | |
Collapse
|
18
|
Mangar SA, Sydes MR, Tucker HL, Coffey J, Sohaib SA, Gianolini S, Webb S, Khoo VS, Dearnaley DP. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: Using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397). Radiother Oncol 2006; 80:355-62. [PMID: 16949694 DOI: 10.1016/j.radonc.2006.07.037] [Citation(s) in RCA: 71] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2006] [Revised: 07/16/2006] [Accepted: 07/24/2006] [Indexed: 11/16/2022]
Abstract
AIM To evaluate the relationship between erectile function and the radiation dose to the penile bulb and other proximal penile structures in men receiving conformal radiotherapy (CFRT) for prostate cancer (PCa). METHODS The Medical Research Council (MRC) RT01 trial randomised 843 men who had localised PCa to receive either 64 or 74 Gy after 3 - 6 months neoadjuvant hormonal treatment. Fifty-one men were selected who were potent prior to hormonal treatment, having completed both pre-hormone and 2-year post-CFRT Quality of Life assessments, and on whom dose volume data were available for analysis. The men were divided into three groups according to 2-year follow-up: potent, reduced potency, and impotent. The bulb of the penis together with the crura, were outlined on restored treatment plans. Dose - volume histograms were generated and compared between the three groups. An ordered logistic regression model was used to calculate the odds ratio of a range of dose - volume parameters to the penile bulb and effect on erectile dysfunction. The dose to the penile bulb was correlated to the dose received by the crura. RESULTS Of the 51 patients, 12 remained potent, 22 had reduced potency, and 17 were impotent at 2 years. No differences were seen in mean dose to the penile bulb by allocated treatment (t test = 1.61, p = 0.11). The mean doses to the penile bulb received by the potent, reduced potency, and impotent groups were 45.5 Gy (SD 17.1), 48 Gy (SD 16.1), and 59.2 Gy (SD 13.8), respectively. There was a strong correlation between the mean dose received by the penile bulb and dose to the crura (r = 0.82, p < 0.0001). 83.3% of impotent patients received a D90 > or = 50 Gy to the penile bulb compared with 29.4% of patients who maintained potency at 2 years (p = 0.006). CONCLUSION There is evidence from this study to suggest a dose volume effect on the penile bulb and erectile dysfunction. A D90 > or = 50 Gy is associated with a significant risk of erectile dysfunction and this should form a basis for selecting dose constraints in future dose escalation studies.
Collapse
Affiliation(s)
- Stephen A Mangar
- Academic Department of Radiotherapy and Oncology, The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Sutton, Surrey, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Scheib S, Crescenti R, Vogelsanger W, Schenkel Y, Gianolini S, Lazaridis E, Mack A. Einsatz normoxischer Polymergele in der 3D-Dosimetrie für die Radiochirurgie. Z Med Phys 2006; 16:180-7. [PMID: 16986457 DOI: 10.1078/0939-3889-00313] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
The aim of this study was to describe the manufacture of normoxic polymer gels, to characterize their dose response relationship, to optimize MR imaging parameters in order to minimize the standard deviation in the measured dose and to use the gel in a dose verification experiment in radiosurgery. The normoxic polymer gel used is simple to manufacture under normal atmospheric conditions and is characterized by a linear dose relationship up to 40 Gy. MR imaging was performed using 2-dimensional (20) single spin echo pulse sequences with two different echo times. The imaging parameters were optimized in order to minimize the standard deviation of the measured transversal relaxation rate R2 and to achieve a geometrical resolution of 1.5 mm. Comparisons of calculated and measured relative 3D dose distributions using a multi isocentric irradiation with Gamma Knife B showed a good overall agreement of both the isodose levels and the differential and cumulative dose volume histograms. The standard deviation in the measured dose was approximately 9% at 30 Gy. The evaluation according to the gamma criterion showed that 96% of the dose voxels remained within a spatial uncertainty of 1.5 mm and a dose uncertainty of 8%.
Collapse
Affiliation(s)
- Stefan Scheib
- Abteilung für Medizinische Strahlenphysik, Klinik Im Park, Zürich.
| | | | | | | | | | | | | |
Collapse
|
20
|
Abstract
BACKGROUND A high degree of precision and accuracy in radiosurgery is a fundamental requirement for therapeutic success. Small radiation fields and steep dose gradients are clinically applied thus necessitating a dedicated quality assurance program in order to guarantee dosimetric and geometric accuracy. MATERIAL AND METHODS A detailed analysis of the course of treatment independent of the irradiation technique used results in the so-called chain of uncertainties in radiosurgery (immobilisation, imaging, treatment planning system, definition of regions of interest, mechanical accuracy, dose planning, dose verification). Each link in this chain is analysed for accuracy and the established quality assurance procedures are discussed. A "System Test" was used to check the whole chain of uncertainties simultaneously. RESULTS The tests described are compatible with published reports on quality assurance in radiosurgery. In terms of accuracy the weakest link in the chain of uncertainties is stereotactic MR imaging. Geometric overall accuracy measured in the "System Test" is less than 0.7 mm. CONCLUSION The established quality assurance routines have clinically been validated. MR imaging dominates geometric overall accuracy in radiosurgery, which can be limited to less than 1 mm by an adequate quality assurance protocol.
Collapse
MESH Headings
- Adenoma/diagnosis
- Adenoma/surgery
- Angiography, Digital Subtraction/instrumentation
- Angiography, Digital Subtraction/standards
- Artifacts
- Brain Neoplasms/diagnosis
- Brain Neoplasms/surgery
- Equipment Design
- Follow-Up Studies
- Humans
- Image Processing, Computer-Assisted/instrumentation
- Image Processing, Computer-Assisted/standards
- Imaging, Three-Dimensional/instrumentation
- Imaging, Three-Dimensional/standards
- Magnetic Resonance Imaging/instrumentation
- Magnetic Resonance Imaging/standards
- Neurilemmoma/diagnosis
- Neurilemmoma/surgery
- Neuronavigation/instrumentation
- Neuronavigation/standards
- Phantoms, Imaging
- Pituitary Neoplasms/diagnosis
- Pituitary Neoplasms/surgery
- Quality Assurance, Health Care/standards
- Radiosurgery/instrumentation
- Radiosurgery/standards
- Sensitivity and Specificity
- Stereotaxic Techniques/instrumentation
- Tomography, X-Ray Computed/instrumentation
- Tomography, X-Ray Computed/standards
Collapse
Affiliation(s)
- S G Scheib
- Department of Medical Radiation Physics, Klinik Im Park, Zurich, Switzerland.
| | | | | | | |
Collapse
|
21
|
Mack A, Mack G, Scheib S, Czempiel H, Kreiner HJ, Lomax NJ, Gianolini S, Rieker M, Weltz D, Wolff R, Muacevic A, Wowra B, Böttcher HD, Seifert V. Quality Assurance in Stereotactic Radiosurgery/Radiotherapy according to DIN 6875-1. Stereotact Funct Neurosurg 2005; 82:235-43. [PMID: 15637445 DOI: 10.1159/000083175] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The new DIN ('Deutsche Industrie-Norm') 6875-1, which is currently being finalised, deals with quality assurance (QA) criteria and tests methods for linear accelerator and Gamma Knife stereotactic radiosurgery/radiotherapy including treatment planning, stereotactic frame and stereotactic imaging and a system test to check the whole chain of uncertainties. Our existing QA program, based on dedicated phantoms and test procedures, has been refined to fulfill the demands of this new DIN. The radiological and mechanical isocentre corresponded within 0.2 mm and the measured 50% isodose lines were in agreement with the calculated ones within less than 0.5 mm. The measured absorbed dose was within 3%. The resultant output factors measured for the 14-, 8- and 4-mm collimator helmet were 0.9870 +/- 0.0086, 0.9578 +/- 0.0057 and 0.8741 +/- 0.0202, respectively. For 170 consecutive tests, the mean geometrical accuracy was 0.48 +/- 0.23 mm. Besides QA phantoms and analysis software developed in-house, the use of commercially available tools facilitated the QA according to the DIN 6875-1 with which our results complied.
Collapse
Affiliation(s)
- A Mack
- Gamma Knife Centre Frankfurt, GKF GmbH, DE-60258 Frankfurt, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
|
23
|
|
24
|
Fiorino C, Gianolini S, Nahum AE. A cylindrical model of the rectum: comparing dose-volume, dose-surface and dose-wall histograms in the radiotherapy of prostate cancer. Phys Med Biol 2003; 48:2603-16. [PMID: 12974577 DOI: 10.1088/0031-9155/48/16/303] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The calculation of the percentage cumulative histogram of the rectal wall (DWH) in prostate cancer radiotherapy may be subject to large uncertainties due to the difficulty of assessing the wall thickness on CT images. For this reason often only the external contour is used to define the rectum and then the percentage cumulative dose-volume histogram (DVH) of the rectum including any filling is calculated as a 'surrogate' for the DWH. More recently, other approaches using only the external contour have been proposed to estimate the DWH such as the percentage normalized dose-surface histograms (NDSH). A similar concept can be used when considering the solid rectum (the percentage normalized DVH, NDVH). The purpose of this investigation was to assess the relationships between rectal DVH, NDVH, DSH, NDSH and DWH in the common case of three- and four-field techniques in prostate cancer irradiation. Analytical relationships between the above parameters have been derived for a cylindrical rectum model in the case of three- and four-field techniques. The model is applied to the case of an empty rectum, a full rectum and to the more realistic mixed full/empty rectum situation for a four-field technique delivering 76 Gy (ICRU dose) with 18 MV x-rays. Different positions of the lateral beam with respect to the rectum axis were simulated. In the case of no lumen variation along the z-axis, the DWH is found to be very close to the DVH and to the DSH for empty and full rectum, respectively. The largest differences (up to 15%) between DVH and DSH were seen in the high-dose region (>70 Gy). In the more realistic case of lumen variation along the z-axis, the DWH always lies between NDVH and NDSH and, excluding the full-rectum situation, the DWH differs from the DVH by less than 7% in the 50-75 Gy range. In the case of significant portions of rectum being completely shielded, the DVH may differ from the NDVH/NDSH/DWH by up to 10-15%. In most clinical situations NDVH is within a few per cent of DWH, whilst NDSH may differ from DWH by up to 15-20%, especially in the high-dose region (V70). In conclusion, for most situations, the DVH is highly correlated with NDVH and DWH. A high degree of consistency between NDVH and DWH was found in most clinical cases whilst largest deviations between NDSH and DWH were evident in the high-dose region (70-75 Gy). In the less common case of a very full rectum a poorer correlation between DVH/NDVH and DWH was found whilst NDSH mimicked the DWH very well. In summary, except for the case of a 'very full' rectum, NDVH may be used as a robust surrogate for DWH. The DVH seems to be sufficiently robust if the rectum is prevalently empty.
Collapse
Affiliation(s)
- Claudio Fiorino
- Medical Physics, Servizio di Fisica Sanitaria, H S Raffaele, Via Olgettina 60, 20132 Milano, Italy.
| | | | | |
Collapse
|
25
|
Abstract
Object. The authors sought to demonstrate the possible value of three-dimensional dose verification by using gel dosimetry.
Methods. In this study, commercially available BANG—25 Gy gel was used. This polymer gel is tissue equivalent and the relaxation rate (R2) measured using magnetic resonance (MR) imaging is proportional to the absorbed dose in the gel. A cylindrical container filled with BANG was mounted within an anthropomorphic head phantom and was handled using the same process as would be used for a patient undergoing gamma knife radiosurgery (GKS). An irregular target outline was constructed and a dose plan was created consisting of seven shots, three using the 8-mm and four using the 4-mm collimator helmet. The maximum dose specified was 25 Gy. A combination of several single spin-echo MR imaging sequences with different echo times was used to calculate the R2. The geometric resolution of the MR images was approximately 1 mm3. To compare the measured dose distribution with the calculated one, isodoses were overlaid in three orthogonal planes by using specially designed analysis software.
Conclusions. Comparisons of the measured and calculated relative dose distributions showed good overall agreement, with differences of less than 3 mm between measured and calculated isodoses.
High resolution BANG gel dosimetry for GKS can be useful for the verification of clinical treatment plans, especially when multiple shots are involved. Further verifications will be done using additional imaging parameters and absolute dose calibrations to improve the method.
Collapse
|
26
|
Mack A, Scheib SG, Major J, Gianolini S, Pazmandi G, Feist H, Czempiel H, Kreiner HJ. Precision dosimetry for narrow photon beams used in radiosurgery-determination of Gamma Knife output factors. Med Phys 2002; 29:2080-9. [PMID: 12349929 DOI: 10.1118/1.1501138] [Citation(s) in RCA: 87] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Treatment units for radiosurgery, like Leksell Gamma Knife and adapted, or dedicated, linear accelerators use small circular beams of ionizing radiation down to 4 mm in diameter at the isocenter. By cross-firing, these beams generate a high dose region at the isocenter together with steep dose gradients of up to 30% per mm. These units are used to treat small complex shaped lesions, often located close to critical structures within the brain, by superimposing several single high dose regions. In order to commission such treatment units for stereotactic irradiations, to carry out quality assurance and to simulate treatment conditions, as well as to collect input data for treatment planning, a precise dosimetric system is necessary. Commercially available radiation dosimeters only partially meet the requirements for narrow photon beams and small field sizes as used in stereotactic treatment modalities. The aim of this study was the experimental determination of the output factors for the field defining collimators used in Gamma Knife radiosurgery, in particular for the smallest, the 4 mm collimator helmet. For output factor measurements a pin point air ionization chamber, a liquid ionization chamber, a diode detector, a diamond detector, TLD microcubes and microrods, alanine pellets, and radiochromic films were used. In total, more than 1000 measurements were performed with these different detection systems, at the sites in Munich and Zurich. Our results show a resultant output factor for the 4 mm collimator helmet of 0.8741 +/- 0.0202, which is in good agreement with recently published results and demonstrates the feasibility of such measurements. The measured output factors for the 8 mm and 14 mm collimator helmets are 0.9578 +/- 0.0057 and 0.9870 +/- 0.0086, respectively.
Collapse
|
27
|
Scheib SG, Gianolini S, Haller D, Wellis GN, Siegfried J. VOLUMESERIES: a software tool for target volume follow-up studies with computerized tomography and magnetic resonance imaging. J Neurosurg 2000. [DOI: 10.3171/jns.2000.93.supplement_3.0203] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
In clinical follow-up studies after radiosurgery, imaging modalities such as computerized tomography (CT) and magnetic resonance (MR) imaging are used. Accurate determination of the residual lesion volume is necessary for realistic assessment of the effects of treatment. Usually, the diameters rather than the volume of the lesion are measured. To determine the lesion volume without using stereotactically defined images, the software program VOLUMESERIES has been developed.
VOLUMESERIES is a personal computer—based image analysis tool. Acquired DICOM CT scans and MR image series can be visualized. The region of interest is contoured with the help of the mouse, and then the system calculates the volume of the contoured region and the total volume is given in cubic centimeters. The defined volume is also displayed in reconstructed sagittal and coronal slices. In addition, distance measurements can be performed to measure tumor extent.
The accuracy of VOLUMESERIES was checked against stereotactically defined images in the Leksell GammaPlan treatment planning program. A discrepancy in target volumes of approximately 8% was observed between the two methods. This discrepancy is of lesser interest because the method is used to determine the course of the target volume over time, rather than the absolute volume. Moreover, it could be shown that the method was more sensitive than the tumor diameter measurements currently in use.
VOLUMESERIES appears to be a valuable tool for assessing residual lesion volume on follow-up images after gamma knife radiosurgery while avoiding the need for stereotactic definition.
Collapse
|
28
|
Müller R, Koller B, Hildebrand T, Laib A, Gianolini S, Rüegsegger P. Resolution dependency of microstructural properties of cancellous bone based on three-dimensional mu-tomography. Technol Health Care 1996; 4:113-9. [PMID: 8773313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Micro-computed tomography (microCT) is an emerging technique for the non-destructive assessment and analysis of the three-dimensional cancellous bone architecture. However, the procedures the procedures and applications used to quantify bone structures are not yet standardized. The aim of this study was to provide more insight in the resolution-dependency of microstructural properties of three-dimensional trabecular bone. Ten iliac crest bone biopsies were measured using a newly devised microCT system providing a nominal isotropic resolution of 14 microns. To study the resolution dependency the measured data were reconstructed on reduced image arrays with reduction factors ranging from 2 to 20. To assess the structural properties, morphometric parameters were computed based on a truly three-dimensional approach. The results showed a strong resolution dependency of the structural properties and that, if very precise results are needed, only the highest resolution will predict the correct values. Nevertheless, since the properties either decrease or increase monotonously up to a nominal resolution of about 175 microns, the values appear to be restorable using a suitable calibration procedure.
Collapse
Affiliation(s)
- R Müller
- Institute for Biomedical Engineering, University of Zürich, Switzerland.
| | | | | | | | | | | |
Collapse
|
29
|
Müller R, Koller B, Hildebrand T, Laib A, Gianolini S, Rüegsegger P. Resolution dependency of microstructural properties of cancellous bone based on three-dimensional μ-tomography. Technol Health Care 1996. [DOI: 10.3233/thc-1996-4112] [Citation(s) in RCA: 120] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- R. Müller
- Institute for Biomedical Engineering, University of Zurich and Swiss Federal Institute of Technology (ETH), Moussonstrasse 18, CH-8044 Zurich, Switzerland
| | - B. Koller
- Institute for Biomedical Engineering, University of Zurich and Swiss Federal Institute of Technology (ETH), Moussonstrasse 18, CH-8044 Zurich, Switzerland
| | - T. Hildebrand
- Institute for Biomedical Engineering, University of Zurich and Swiss Federal Institute of Technology (ETH), Moussonstrasse 18, CH-8044 Zurich, Switzerland
| | - A. Laib
- Institute for Biomedical Engineering, University of Zurich and Swiss Federal Institute of Technology (ETH), Moussonstrasse 18, CH-8044 Zurich, Switzerland
| | - S. Gianolini
- Institute for Biomedical Engineering, University of Zurich and Swiss Federal Institute of Technology (ETH), Moussonstrasse 18, CH-8044 Zurich, Switzerland
| | - P. Rüegsegger
- Institute for Biomedical Engineering, University of Zurich and Swiss Federal Institute of Technology (ETH), Moussonstrasse 18, CH-8044 Zurich, Switzerland
| |
Collapse
|